Engeneic
Advertisement
EnGeneIC, located in Lane Cove West, New South Wales, specializes in the research, development, and manufacturing of targeted anticancer therapies, utilizing a unique platform known as the EDV nanocell. This first-in-class cytoimmunotherapy technology targets tumors directly while harnessing the patient's own immune system for more effective treatment outcomes.
Recently, EnGeneIC has made headlines by launching a groundbreaking clinical trial that evaluates the safety and efficacy of its EGFR-targeted EDV nanocells, which are designed to deliver a potent cytotoxic drug along with an immunostimulating adjuvant. With a commitment to advancing innovative cancer therapies, EnGeneIC is set to progress its novel platform technology from clinical trials to the market.
Generated from the website
Also at this address
You might also like
Advertisement